{"filing":{"accession_number":"0001493152-26-040926","cik":"0001857044","ticker":"INDP","company_name":"Indaptus Therapeutics, Inc.","form":"8-K","filing_date":"2026-09-01","report_date":"2026-08-28","primary_document":"form8-k.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1857044/000149315226040926/form8-k.htm"},"events":[{"id":30785,"run_id":28225,"accession_number":"0001493152-26-040926","anchor_item_number":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"summary":"The filing discloses entry into an Amended and Restated At-the-Market (ATM) Offering Agreement with H.C. Wainwright \u0026 Co., LLC, authorizing the issuance of up to $100,000,000 in common stock shares. This is a registered equity offering program that will dilute existing shareholders and is a material capital-raising activity typical of small-cap biotech companies. The ATM structure allows continuous issuance at market prices, making this a dilutive equity issuance under Item 1.01.","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-09-01","form":"8-K","submitted_at":null,"items":null}],"classifications":[{"id":33495,"accession_number":"0001493152-26-040926","item_number":null,"item_title":null,"event_type":"dilutive_issuance","event_domain":"financial","is_material":true,"confidence":0.85,"reasoning":"The filing discloses entry into an Amended and Restated At-the-Market (ATM) Offering Agreement with H.C. Wainwright \u0026 Co., LLC, authorizing the issuance of up to $100,000,000 in common stock shares. This is a registered equity offering program that will dilute existing shareholders and is a material capital-raising activity typical of small-cap biotech companies. The ATM structure allows continuous issuance at market prices, making this a dilutive equity issuance under Item 1.01.","classifier_version":"claude-haiku-4-5-20251001+prompt-a85dd512","taxonomy_version":"v1.3","classified_at":"2026-09-01T11:31:41.908847+00:00","company_name":"Indaptus Therapeutics, Inc.","ticker":"INDP","filing_date":"2026-09-01"}]}